Your browser doesn't support javascript.
loading
Clinical-Hematological Changes and Predictors of Severity in Acute Food Protein-Induced Enterocolitis Syndrome Reactions at Oral Food Challenge: A Multicenter Observational Study.
Argiz, L; Valsami-Fokianos, M; Arasi, S; Barni, S; Boscia, S; Bracaglia, G; Bracamonte, T; Carballeira, I; Dinardo, G; Echeverria, L; Garcia, E; Garcia-Magan, C; Gomez-Rial, J; Gonzalez-Delgado, P; Fiocchi, A; Garriga, T; Ibrahim, T; Infante, S; Machinena, A; Mangone, G; Mori, F; Moure, J D; O'Valle, V; Pascal, M; Pecora, V; Prieto, A; Quevedo, S; Salas, A; Vazquez-Cortes, S; Vila, L; Martinon-Torres, F; Gomez-Carballa, A; Boyle, R J; Vazquez-Ortiz, Marta.
Afiliación
  • Argiz L; Department of Allergy, Clínica Universidad de Navarra, Pamplona, Spain; RICORS Red De Enfermedades Inflamatorias (REI) - RD21/0002/0028, Madrid, Spain.
  • Valsami-Fokianos M; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Arasi S; Allergy Unit, Department of Pediatric Medicine, Bambino Gesù Children's Research Hospital, IRCCS, Rome, Italy.
  • Barni S; Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Boscia S; Division of Immunology, Meyer Children's Hospital IRCCS, Florence, Italy; Department of Health Sciences, University of Florence, Florence, Italy.
  • Bracaglia G; Laboratory Medicine, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
  • Bracamonte T; Paediatric Allergy Section, Severo Ochoa University Hospital, Madrid, Spain.
  • Carballeira I; Paediatric Allergy Section, Arquitecto Marcide Hospital, Coruña, Spain.
  • Dinardo G; Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli," Naples, Italy.
  • Echeverria L; Paediatric Allergy Section, Severo Ochoa University Hospital, Madrid, Spain.
  • Garcia E; Paediatric Allergy Section, Arquitecto Marcide Hospital, Coruña, Spain.
  • Garcia-Magan C; Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Coruña, Spain.
  • Gomez-Rial J; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Gonzalez-Delgado P; Allergy Department, General University Hospital, Alicante, Spain.
  • Fiocchi A; Allergy Unit, Department of Pediatric Medicine, Bambino Gesù Children's Research Hospital, IRCCS, Rome, Italy.
  • Garriga T; Paediatric Allergy Section, Vall D'Hebron University Hospital, Growth and Development Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Ibrahim T; National Heart and Lung Institute, Imperial College London, London, United Kingdom; Allergy and Immunology Division, Hamad Medical Corporation, Doha, Qatar.
  • Infante S; Pediatric Allergy Unit, Hospital General Universitario Gregorio Marañón, Gregorio Marañón Health Research Institute, IiSGM, Madrid, Spain.
  • Machinena A; Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Mangone G; Division of Immunology, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Mori F; Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Moure JD; Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Coruña, Spain.
  • O'Valle V; Paediatric Allergy Section, Severo Ochoa University Hospital, Madrid, Spain.
  • Pascal M; Immunology Department, CDB, Hospital Clínic de Barcelona, Barcelona, Spain; IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Pecora V; Allergy Unit, Department of Pediatric Medicine, Bambino Gesù Children's Research Hospital, IRCCS, Rome, Italy.
  • Prieto A; Paediatric Allergy Section, General University Hospital, Malaga, Spain.
  • Quevedo S; Paediatric Allergy Section, Severo Ochoa University Hospital, Madrid, Spain.
  • Salas A; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain; Unidade de Xenética, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela,
  • Vazquez-Cortes S; Allergy Department, Clinico San Carlos Hospital, Madrid, Spain.
  • Vila L; Paediatric Allergy Section, Teresa Herrera Hospital, Coruña, Spain.
  • Martinon-Torres F; Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Coruña, Spain; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain; Centro de Investig
  • Gomez-Carballa A; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain; Unidade de Xenética, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela,
  • Boyle RJ; Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Vazquez-Ortiz M; Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: m.vazquez-ortiz@imperial.ac.uk.
Article en En | MEDLINE | ID: mdl-38796100
ABSTRACT

BACKGROUND:

Oral food challenge (OFC) is the criterion standard for diagnosis of acute food protein-induced enterocolitis syndrome (FPIES). No diagnostic/prognostic biomarkers are available, and OFC assessment criteria are not validated.

OBJECTIVE:

To assess clinical-hematological changes and predictors of severity of FPIES reactions at OFC.

METHODS:

This was an observational multicenter prospective study. Children aged 0 to 18 years diagnosed with acute FPIES were recruited at follow-up OFC in 12 tertiary centers in Spain and Italy. OFC outcomes (as positive/negative/inconclusive and mild/moderate/severe) were assessed on the basis of published "2017 FPIES Consensus" criteria. Clinical characteristics were recorded, and full blood cell count was done at baseline, reaction onset, and 4 hours later. Regression analysis was performed to assess predictors of severe reactions at OFC.

RESULTS:

A total of 81 children had positive OFC (mild in 11% [9 of 81], moderate in 61% [49 of 81], and severe in 28% [23 of 81]). Increase in neutrophils and reduction in eosinophils, basophils, and lymphocytes were observed (P < .05). OFC was inconclusive in 19 cases despite objective signs or neutrophilia. Regression analysis showed that a 2-day OFC protocol where only 25% of an age-appropriate portion is given on day 1 (not sex, age, culprit food, cumulative dose, and previous reaction severity) was associated with reduced odds of severe reaction compared with giving multiple doses in a single day.

CONCLUSIONS:

Distinct hematological changes may help support FPIES diagnosis. Current OFC assessment criteria may not capture the broad spectrum of acute FPIES presentations. This 2-day protocol may be associated with a reduced risk of severe reactions. Future work should aim to develop safer OFC and non-OFC diagnostics for FPIES.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2024 Tipo del documento: Article País de afiliación: España